Soluble tumour necrosis factor-α receptor type 1 as a biomarker of response to phototherapy in patients with psoriasis

Biomarkers

Volumn 12, Issue 6, 2007, Pages 599-607

  Serwin, Agnieszka B ^a   Chodynicka, Bozena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Narrowband ultraviolet B; Psoriasis; Soluble tumour necrosis factor receptor type 1; Systemic photochemotherapy

Indexed keywords

ANTIPSORIASIS AGENT; BIOLOGICAL MARKER; EMOLLIENT AGENT; METHOXSALEN; PSORALEN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PROTEIN BLOOD LEVEL; PSORIASIS; PUVA; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION;

ADULT; BIOLOGICAL MARKERS; DOWN-REGULATION; FEMALE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PSORIASIS; PUVA THERAPY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 35748973883     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500701600597     Document Type: Article

References (21)

1. Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C. and Wallach, D. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Journal of Experimental Medicine, 175, pp. 323-329.
2. Barr, RM, Walker, SL, Tsang, W., Harrison, GJ, Ettehadi, MW, Graves, MW and Young, AR (1999) Suppressed alloantigen presentation, increased TNF-α, IL-1, IL-1Ra, IL-10, and modulation of TNF-R1 in UV-irradiated human skin. Journal of Investigative Dermatology, 112, pp. 692-698.
3. Brockhaus, M., Schoenfeld, H-J, Schlaeger, E-J, Hunziker, W., Lessauer, W. and Loetscher, H. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proceedings of the National Academy of Sciences USA, 87, pp. 3127-3131.
4. Chaudhari, U., Romano, P., Mulcahy, LD, Dooley, LT, Baker, DG and Gottlieb, AB (2001) Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomized trial. Lancet, 35, pp. 1842-1847.
5. Ettehadi, P., Greaves, MW, Wallach, D., Aderka, D. and Camp, DR (1994) Elevated tumor necrosis factor alpha (TNF-α) biological activity in psoriatic skin lesions. Clinical & Experimental Immunology, 96, pp. 146-151.
6. Fredriksson, T. and Petersson, V. (1978) Severe psoriasis: Oral therapy with a new retinoid. Dermatologica, 157, pp. 238-244.
7. Griffiths, CEM, Boffa, MJ, Gallatin, WM and Martin, S. (1996) Elevated levels of circulating intercellular adhesion molecule-3 (cICAM-3) in psoriasis. Acta Dermato-Venereologica (Stockholm), 76, pp. 2-5.
8. Henseler, T. and Chrisophers, E. (1985) Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. Journal of the American Academy of Dermatology, 13, pp. 450-456.
9. Hönigsmann, H. (2001) Phototherapy for psoriasis. Clinical and Experimental Dermatology, 26, pp. 343-350.
10. Kirby, B., Boffa, MJ, Nayak, N., Gallatin, WM, Martin, S. and Griffiths, CEM (2001) The effect of treatment on serum levels of soluble intercellular adhesion molecules and tumour necrosis factor-receptor 1 in psoriasis. British Journal of Dermatology, 145, pp. 1027-1028.
11. Köck, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., Ansel, JC and Luger, TA (1990) Human kernatinocytes are a source for tumor necrosis factor. Evidence for synthesis and release upon stimulation by endotoxin or ultraviolet light. Journal of Experimental Medicine, 172, pp. 1609-1614.
12. Kristensen, M., Chu, CQ, Eedy, DJ, Feldman, M., Brennan, FM and Breathnach, SM (1993) Localization of tumor necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: Epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clinical and Experimental Immunology, 94, pp. 354-362.
13. Mease, PJ, Goffe, BS, Metz, J., VanderStoep, A., Finck, B. and Burge, DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet, 356, pp. 1627-1632.
14. Naldi, L. and Griffiths, CEM (2005) Traditional therapies in the management of moderate to severe chronic plaque psoriasis: An assessment of the benefits and risks. British Journal of Dermatology, 152, pp. 597-615.
15. Neuner, P., Charvat, B., Knobler, R., Kirnbauer, R., Schwarz, A. and Luger, TA (1994) Cytokine release by peripheral blood mononuclear cells is affected by 8-methoxypsoralen plus UV-A. Photochemistry and Photobiology, 59, pp. 182-188.
16. Olaniran, AK, Baker, BS, Paige, DG, Garioch, JJ, Powels, AV and Fry, L. (1996) Cytokine expression in psoriatic skin lesions during PUVA therapy. Archives of Dermatological Research, 288, pp. 421-425.
17. Piskin, G., Tursen, U., Sylva-Steenland, RMR, Bos, JD and Teunissen, MBM (2004) Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of INF-γ inducers - IL-1, IL-18 and IL-23. Experimental Dermatology, 13, pp. 764-772.
18. Schwarz, T. and Luger, TA (1989) New trends in photobiology: Effect of UV irradiation on epidermal cell cytokine production. Journal of Photochemistry and Photobiology B, 4, pp. 1-13.
19. Serwin, AB, Sokolowska, M. and Chodynicka, B. (2005) Soluble tumor necrosis factor α receptor type 1 in psoriasis patients treated with narrowband ultraviolet B. Photodermatology, Photoimmunology and Photomedicine, 21, pp. 210-211.
20. Terajima, S., Higaki, M., Igarashi, Y., Nogita, T. and Kawashima, M. (1998) An important role of tumor necrosis factor-α in the induction of adhesion molecules in psoriasis. Archives of Dermatological Research, 290, pp. 246-252.
21. Trefzer, U., Brockhaus, M., Lötscher, H., Parlow, F., Budnik, A., Grewe, M., Christoph, H., Kapp, A., Schöpf, E., Luger, TA and Krutmann, J. (1993) The 55-kD tumor necrosis factor receptor on human keratinocytes is regulated by tumor necrosis factor-alpha and by ultraviolet B radiation. Journal of Clinical Investigation, 92, pp. 462-470.